Profund Advisors’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
OAM
Profund Advisors's ASTH Position: Q1 2022 in Review
Profund Advisors sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 3,478 shares — an estimated $256K sold.
Profund Advisors first reported a position in ASTH in Q3 2021 and held it in 2 quarters. The position peaked at $345K in Q3 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.
- Profund Advisors reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
- Profund Advisors sold 3,478 Astrana Health shares in Q1 2022, an estimated $256K.
- Profund Advisors first reported a position in Astrana Health in Q3 2021 and held it in 2 quarters.
- Profund Advisors's Astrana Health position peaked at $345K in Q3 2021.
- 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.
Based on Profund Advisors's 13F filing for Q1 2022, filed 10 May 2022.